Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder
DOI:
https://doi.org/10.5489/cuaj.9576Keywords:
bladder cancer, radical cystectomy, delay, pathologic upstaging, overall survivalAbstract
Introduction: A delay beyond 12 weeks from diagnosis to radical cystectomy (RC) is considered to impart worse oncologic outcomes for patients with muscle-invasive bladder cancer (MIBC); however, no randomized clinical trials have examined this question. We therefore emulated a hypothetical target clinical trial using contemporary data to evaluate the association between time from diagnosis to RC and oncologic outcomes.
Methods: We conducted observational analyses using the National Cancer Database from 2006−2015 to emulate a hypothetical target trial in adults aged 40−79 years with incident cT2−4 N0 M0 urothelial carcinoma of the bladder, treated with RC from 4−18 weeks after diagnosis. We evaluated the association of late RC with pathologic upstaging at RC and overall survival (OS) and conducted exploratory analyses evaluating the association of time to RC with each outcome modeled flexibly.
Results: A total of 3747 patients were included, of which 2992 underwent early RC. Median followup was 32.2 months. In adjusted analyses, late RC was not associated with an increased risk of pathologic upstaging compared to early RC. In addition, there was no statistically significant difference in adjusted OS for late and early RC, respectively. Similar findings were observed across categories of cT stage, age, Charlson index, and gender.
Conclusions: In observational analyses designed to emulate a hypothetical target trial of early vs. late RC, the timing of RC was not associated with a statistically significant increase in pathologic upstaging or a difference in OS when performed from 4−18 weeks after diagnosis. These results suggest the need to re-examine the traditional recommendations for timing of RC following diagnosis.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.


